Advertisement

Topics

Search Results for "Graves Disease And Agent Orange "

03:20 EDT 25th September 2016 | BioPortfolio

Matching Channels

Graves' disease

Congenital Graves' disease

Eye disease

Xofigo (radium-223 dichloride)

New treatment for castration-resistant prostate cancer (CRPC) patients with bone metastases. Xofigo shown in a pivotal phase III trial to significantly improve overall survival. Xofigo® with...

p38 mitogen activated protein kinase MAPK Inhibitors

The next generation of p38 mitogen-activated protein kinase (MAPK) inhibitors has reached clinical proof-of-concept studies in phase II in a broad range of indications. While the previous generation o...

Matching News

Later onset, longer duration of Graves’ hyperthyroidism, smoking predictors for Graves’ orbitopathy

In patients with Graves’ hyperthyroidism, predictive factors for Graves’ orbitopathy include older age of disease onset, longer disease duration and smoking, according to recent findings in a larg...

Treatment Options in the Young Patient With Graves' Disease

In this review, the advantages and disadvantages of available treatment options for young patients with Graves disease are discussed. Clinical Endocrinology

Interprofessional education good for health care, optometry, patients

Just the other day a long-term patient presented with acute onset diplopia. While her demographic profile and clinical findings were consistent with a subtle ischemic sixth nerve palsy, my differentia...

NRDC plays scary Agent Orange card about 2,4-D herbicide found safe by regulators

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis. There has been a long-running scare campaign against the commonly-used herbicide 2,4-D, whic...

Role of infectious agent in Alzheimer’s Disease?

Role of infectious agent in Alzheimer’s Disease? Larry H. Bernstein, MD, FCAP, Curator LPBI   Role of Infection in Alzheimer’s Ignored, Experts Say Nancy A. Melville   http://www.me...

[Seminar] Hyperthyroidism

Hyperthyroidism is characterised by increased thyroid hormone synthesis and secretion from the thyroid gland, whereas thyrotoxicosis refers to the clinical syndrome of excess circulating thyroid hormo...

Novel cells, delivery procedure in development for retinal diseases

COPENHAGEN — A novel agent derived from human umbilical tissue and a novel system to deliver the agent suprachoroidally may ultimately benefit patients with retinal disease, according to Christopher...

New ATA Guidelines Tackle Paradigm Shifts in Graves' Disease

The new recommendations address diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis, including the complexity around pregnancy. Medscape Medical News

Matching PubMed Articles

CD28/CTLA-4/ICOS haplotypes confers susceptibility to Graves' disease and modulates clinical phenotype of disease.

Graves' disease, an autoimmune disease with heterogeneous symptoms including Graves' orbitopathy, has a combined genetic/environmental background, where variations within CD28/CTLA-4/ICOS genes are co...

Management of hyperthyroidism due to Graves' disease: frequently asked questions and answers (if any).

Graves' disease is the most common cause of hyperthyroidism in iodine-replete areas. Although progress has been made in our understanding of the pathogenesis of the disease, no treatment targeting pat...

The management of Graves' disease in New Zealand 2014.

Treatment options for Graves' disease (GD), namely anti-thyroid drugs (ATD), surgery or radioiodine (RAI), have not changed over the past two decades. There is no 'gold-standard' treatment for GD.

Thyrotropin Receptor Antibody (TRAb)-IgM Levels Are Markedly Higher Than TRAb-IgG Levels in Graves' Disease Patients and Controls, and TRAb-IgM Production Is Related to Epstein-Barr Virus Reactivation.

Graves' disease is an autoimmune thyroid disorder that mainly presents as hyperthyroidism and is caused by thyrotropin receptor antibodies (TRAbs) that stimulate thyroid-stimulating hormone receptors....

Radioiodine therapy versus antithyroid medications for Graves' disease.

Graves' disease is the most common cause of hyperthyroidism. Both antithyroid medications and radioiodine are commonly used treatments but their frequency of use varies between regions and countries. ...

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement